{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:01:00Z","timestamp":1790942460466,"version":"4.1.0"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Vaccinia virus (VV) has been used as a vaccine to eradicate smallpox and as a vaccine for HIV and tumors. However, the immunoevasive properties of VV have raised safety concerns. VV infection of APCs perturbs MHC class II-mediated Ag presentation. Exposure of human B cell lines to VV induced a substantial reduction in cellular expression of the class II chaperone, invariant chain (Ii), during the late stages (i.e., 8\u201310 h) of infection. Yet, cell viability and surface expression of MHC class II molecules were maintained up to 24 h after exposure to virus. Reductions in Ii and class II mRNA levels were detected as early as 6 h after VV infection of APCs. To examine whether VV was acting solely to disrupt host protein synthesis, B cells were treated with an inhibitor of translation, cycloheximide (CHX). Within 1 h of B cell CHX treatment, Ii protein expression decreased coupled with a loss of class II presentation. Analysis of Ii degradation in VV- or CHX-treated cells, revealed ongoing Ii proteolysis contributing to reduced steady-state Ii levels in these APC. Yet in contrast with CHX, VV infection of APCs altered lysosomal protease expression and Ii degradation. Virus infection induced cellular cathepsin L expression while reducing the levels of other lysosomal proteases. These results demonstrate that at late stages of VV infection, reductions in cellular Ii levels coupled with changes in lysosomal protease activity, contribute in part to defects in class II presentation.<\/jats:p>","DOI":"10.4049\/jimmunol.0802741","type":"journal-article","created":{"date-parts":[[2009,7,11]],"date-time":"2009-07-11T01:40:49Z","timestamp":1247276449000},"page":"1542-1550","source":"Crossref","is-referenced-by-count":11,"title":["Diminished Intracellular Invariant Chain Expression after Vaccinia Virus Infection"],"prefix":"10.1093","volume":"183","author":[{"given":"Nan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Center for Immunobiology, and Walther Oncology Center, Indiana University School of Medicine , Indianapolis, IN 46202"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Weber","sequence":"additional","affiliation":[{"name":"Institute of Physiological Chemistry, Martin Luther University Halle-Wittenberg , Halle,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice S","family":"Blum","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Center for Immunobiology, and Walther Oncology Center, Indiana University School of Medicine , Indianapolis, IN 46202"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,8,1]]},"reference":[{"key":"2025032619372158000_R1","first-page":"129","article-title":"Progressive vaccinia in immunologically deficient individuals.","volume-title":"Birth Defects Org. Artic. Ser.","year":"1968"},{"key":"2025032619372158000_R2","first-page":"282","article-title":"Progressive vaccinia with normal antibodies. A case possibly due to deficient cellular immunity.","volume-title":"Ann. Intern. Med.","year":"1964"},{"key":"2025032619372158000_R3","first-page":"673","article-title":"Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease.","volume-title":"N. Engl. J. Med.","year":"1987"},{"key":"2025032619372158000_R4","first-page":"137","article-title":"Vaccinia virus immune evasion.","volume-title":"Immunol. Rev.","year":"1997"},{"key":"2025032619372158000_R5","first-page":"325","article-title":"Biogenesis of vaccinia: specific inhibition of rapidly labeled host DNA in vaccinia inoculated cells.","volume-title":"Virology","year":"1976"},{"key":"2025032619372158000_R6","first-page":"529","article-title":"Vaccinia virus induces cellular mRNA degradation.","volume-title":"J. Virol.","year":"1983"},{"key":"2025032619372158000_R7","first-page":"577","article-title":"Messenger RNA in cells infected with vaccinia virus.","volume-title":"Proc. Natl. Acad. Sci. USA","year":"1964"},{"key":"2025032619372158000_R8","first-page":"8707","article-title":"Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.","volume-title":"J. Virol.","year":"2007"},{"key":"2025032619372158000_R9","first-page":"4590","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.","volume-title":"Proc. Natl. Acad. Sci. USA","year":"2004"},{"key":"2025032619372158000_R10","first-page":"6481","article-title":"Disruption of MHC class II-restricted antigen presentation by vaccinia virus.","volume-title":"J. Immunol.","year":"2005"},{"key":"2025032619372158000_R11","first-page":"92","article-title":"Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II.","volume-title":"Cell. Immunol.","year":"2007"},{"key":"2025032619372158000_R12","first-page":"203","article-title":"Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression.","volume-title":"Nat. Immun.","year":"1992"},{"key":"2025032619372158000_R13","first-page":"2055","article-title":"Virus infection blocks the processing and presentation of exogenous antigen with the major histocompatibility complex class II molecules.","volume-title":"Eur. J. Immunol.","year":"1992"},{"key":"2025032619372158000_R14","first-page":"305","article-title":"No recognition of MHC class II+ cells infected with a vaccinia virus encoding influenza type A nucleoprotein by class II-restricted T cells.","volume-title":"Immunol. Lett.","year":"1993"},{"key":"2025032619372158000_R15","first-page":"903","article-title":"Differences in antigen presentation to MHC class I- and class II-restricted influenza virus-specific cytolytic T lymphocyte clones.","volume-title":"J. Exp. Med.","year":"1986"},{"key":"2025032619372158000_R16","first-page":"1069","article-title":"Differential processing and presentation of the H-2Db-restricted epitope from two different strains of influenza virus nucleoprotein.","volume-title":"J. Gen. Virol.","year":"2001"},{"key":"2025032619372158000_R17","first-page":"6265","article-title":"Cellular and humoral immunity against vaccinia virus infection of mice.","volume-title":"J. Immunol.","year":"2004"},{"key":"2025032619372158000_R18","first-page":"100","article-title":"Transient decreases in human T cell proliferative responses following vaccinia immunization.","volume-title":"Clin. Immunol.","year":"2000"},{"key":"2025032619372158000_R19","first-page":"1211","article-title":"Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.","volume-title":"J. Exp. Med.","year":"1988"},{"key":"2025032619372158000_R20","first-page":"10397","article-title":"Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor.","volume-title":"J. Virol.","year":"2005"},{"key":"2025032619372158000_R21","first-page":"265","article-title":"Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo.","volume-title":"Nat. Immunol.","year":"2002"},{"key":"2025032619372158000_R22","first-page":"10","article-title":"Susceptibility of different leukocyte cell types to Vaccinia virus infection.","volume-title":"Virol. J.","year":"2004"},{"key":"2025032619372158000_R23","first-page":"450","article-title":"Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus.","volume-title":"Science","year":"1998"},{"key":"2025032619372158000_R24","first-page":"357","article-title":"Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading.","volume-title":"Immunity","year":"1996"},{"key":"2025032619372158000_R25","first-page":"983","article-title":"Both invariant chain isoforms Ii31 and Ii41 promote class II antigen presentation.","volume-title":"Int. Immunol.","year":"1997"},{"key":"2025032619372158000_R26","first-page":"435","article-title":"Correlation between invariant chain expression level and capability to present antigen to MHC class II-restricted T cells.","volume-title":"Int. Immunol.","year":"1991"},{"key":"2025032619372158000_R27","first-page":"1699","article-title":"Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression.","volume-title":"J. Exp. Med.","year":"1993"},{"key":"2025032619372158000_R28","first-page":"3271","article-title":"Dissecting MHC class II export, B cell maturation, and DM stability defects in invariant chain mutant mice.","volume-title":"J. Immunol.","year":"2004"},{"key":"2025032619372158000_R29","first-page":"277","article-title":"Requirement for protein synthesis in antigen processing by B cells.","volume-title":"Cell. Immunol.","year":"1994"},{"key":"2025032619372158000_R30","first-page":"561","article-title":"Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules.","volume-title":"Traffic","year":"2000"},{"key":"2025032619372158000_R31","first-page":"2444","article-title":"Role of disulfide bonds in regulating antigen processing and epitope selection.","volume-title":"J. Immunol.","year":"2002"},{"key":"2025032619372158000_R32","first-page":"159","article-title":"Monoclonal antibodies against cathepsin L and procathepsin L of different species.","volume-title":"Hybridoma","year":"1997"},{"key":"2025032619372158000_R33","first-page":"489","article-title":"Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone.","volume-title":"Immunity","year":"2003"},{"key":"2025032619372158000_R34","first-page":"3975","article-title":"Role for intracellular proteases in the processing and transport of class II HLA antigens.","volume-title":"Proc. Natl. Acad. Sci. USA","year":"1988"},{"key":"2025032619372158000_R35","first-page":"201","article-title":"Early virus protein synthesis in vaccinia virus-infected cells.","volume-title":"J. Gen. Virol.","year":"1973"},{"key":"2025032619372158000_R36","first-page":"7603","article-title":"A transcriptionally controlled trans-processing assay: putative identification of a vaccinia virus-encoded proteinase which cleaves precursor protein P25K.","volume-title":"J. Virol.","year":"1994"},{"key":"2025032619372158000_R37","first-page":"2225","article-title":"Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors.","volume-title":"J. Virol.","year":"2006"},{"key":"2025032619372158000_R38","first-page":"4480","article-title":"Mechanism of cycloheximide inhibition of protein synthesis in a cell-free system prepared from rat liver.","volume-title":"J. Biol. Chem.","year":"1969"},{"key":"2025032619372158000_R39","first-page":"174","article-title":"The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes.","volume-title":"J. Biol. Chem.","year":"1971"},{"key":"2025032619372158000_R40","first-page":"812","article-title":"MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A.","volume-title":"J. Immunol.","year":"1990"},{"key":"2025032619372158000_R41","first-page":"1513","article-title":"Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins.","volume-title":"J. Exp. Med.","year":"2000"},{"key":"2025032619372158000_R42","first-page":"6168","article-title":"Interaction of human immunodeficiency virus type 2 Vpx and invariant chain.","volume-title":"J. Virol.","year":"2000"},{"key":"2025032619372158000_R43","first-page":"206","article-title":"Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.","volume-title":"Immunol. Rev.","year":"2005"},{"key":"2025032619372158000_R44","first-page":"2894","article-title":"Role of cathepsin D in antigen presentation of ovalbumin.","volume-title":"J. Immunol.","year":"1992"},{"key":"2025032619372158000_R45","first-page":"207","article-title":"Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice.","volume-title":"Immunity","year":"1999"},{"key":"2025032619372158000_R46","first-page":"2175","article-title":"Cathepsin D, but not cathepsin B, releases T cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II MHC molecules.","volume-title":"Eur. J. Immunol.","year":"1994"},{"key":"2025032619372158000_R47","first-page":"1349","article-title":"Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands.","volume-title":"J. Exp. Med.","year":"2002"},{"key":"2025032619372158000_R48","first-page":"881","article-title":"Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells.","volume-title":"J. Exp. Med.","year":"2001"},{"key":"2025032619372158000_R49","first-page":"235","article-title":"Activity and subcellular distribution of cathepsins in primary human monocytes.","volume-title":"J. Leukocyte Biol.","year":"2003"},{"key":"2025032619372158000_R50","first-page":"844","article-title":"Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner.","volume-title":"J. Leukocyte Biol.","year":"2004"},{"key":"2025032619372158000_R51","first-page":"137","article-title":"Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.","volume-title":"J. Immunol.","year":"1995"},{"key":"2025032619372158000_R52","first-page":"121","article-title":"The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation.","volume-title":"Immunol. Rev.","year":"1999"},{"key":"2025032619372158000_R53","first-page":"2876","article-title":"Lysosomal cysteine and aspartic proteases are heterogeneously expressed and act redundantly to initiate human invariant chain degradation.","volume-title":"J. Immunol.","year":"2008"},{"key":"2025032619372158000_R54","first-page":"990","article-title":"Lack of detectable endocytosis of B lymphocyte MHC class II antigens using an antibody-independent technique.","volume-title":"J. Immunol.","year":"1990"},{"key":"2025032619372158000_R55","first-page":"1057","article-title":"Invariant chain controls H2-M proteolysis in mouse splenocytes and dendritic cells.","volume-title":"J. Exp. Med.","year":"2000"},{"key":"2025032619372158000_R56","first-page":"2171","article-title":"Endosomal aspartic proteinases are required for invariant-chain processing.","volume-title":"Proc. Natl. Acad. Sci. USA","year":"1994"},{"key":"2025032619372158000_R57","first-page":"5768","article-title":"Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry.","volume-title":"J. Virol.","year":"2006"},{"key":"2025032619372158000_R58","first-page":"11876","article-title":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.","volume-title":"Proc. Natl. Acad. Sci. USA","year":"2005"},{"key":"2025032619372158000_R59","first-page":"1","article-title":"Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells.","volume-title":"J. Med. Invest.","year":"2005"},{"key":"2025032619372158000_R60","first-page":"27","article-title":"Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas.","volume-title":"Clin. Exp. Metastasis","year":"1996"},{"key":"2025032619372158000_R61","first-page":"5658","article-title":"Rhabdovirus-induced apoptosis in a fish cell line is inhibited by a human endogenous acid cysteine proteinase inhibitor.","volume-title":"J. Virol.","year":"1997"},{"key":"2025032619372158000_R62","first-page":"4186","article-title":"Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells.","volume-title":"J. Virol.","year":"2007"},{"key":"2025032619372158000_R63","first-page":"125","article-title":"Cathepsin L expression is up-regulated by hypoxia in human melanoma cells: role of its 5\u2032-untranslated region.","volume-title":"Biochem. J.","year":"2008"},{"key":"2025032619372158000_R64","first-page":"132","article-title":"Mitochondria-to-nucleus stress signaling in mammalian cells: nature of nuclear gene targets, transcription regulation, and induced resistance to apoptosis.","volume-title":"Gene","year":"2005"},{"key":"2025032619372158000_R65","first-page":"2703","article-title":"Vaccinia peptides eluted from HLA-DR1 isolated from virus-infected cells are recognized by CD4+ T cells from a vaccinated donor.","volume-title":"J. Proteome Res.","year":"2008"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/183\/3\/1542\/62692657\/9389.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/183\/3\/1542\/62692657\/9389.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T19:16:43Z","timestamp":1743275803000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/183\/3\/1542\/8053597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,1]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,8,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.0802741","relation":{},"ISSN":["1550-6606","0022-1767"],"issn-type":[{"value":"1550-6606","type":"electronic"},{"value":"0022-1767","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,8]]},"published":{"date-parts":[[2009,8,1]]}}}